Received May 1, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 27G79 | — |
cellulitis; left thigh swollen; This non-serious case was reported by a non-health professional via call center representative and described the occurrence of cellulitis in a 4-year-old male patient who received DTPa-IPV (Kinrix) (batch number 27G79, expiry date 24-FEB-2028) for prophylaxis. On 10-APR-2026, the patient received Kinrix. In APR-2026, an unknown time after receiving Kinrix, the patient experienced cellulitis (Verbatim: cellulitis) and swelling of legs (Verbatim: left thigh swollen). The outcome of the cellulitis and swelling of legs were unknown. It was unknown if the reporter considered the cellulitis and swelling of legs to be related to Kinrix and Kinrix Pre-Filled Syringe Device. It was unknown if the company considered the cellulitis and swelling of legs to be related to Kinrix and Kinrix Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 22-APR-2026 The patient had a local reaction to the immunization. The patient came back to the office with their left thigh swollen and was diagnosed with cellulitis.; Sender's Comments: GSK-US2026055704:Same reporter US-GSK-US2026055369:SAME REPORTER